(Q39680805)

English

Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells

scientific article published on September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Astrid Schwantes

3

object named as

Astrid Schwantes

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

Joachim Zwilling

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Katja Sliva

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Barbara Schnierle

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

404

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

231-239

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

F11L-mediated inhibition of RhoA-mDia signaling stimulates microtubule dynamics during vaccinia virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Generation of recombinant fowlpox virus using the non-essential F11L orthologue as insertion site and a rapid transient selection strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Vaccinia virus K1L protein mediates host-range function in RK-13 cells via ankyrin repeat and may interact with a cellular GTPase-activating protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

F11-mediated inhibition of RhoA signalling enhances the spread of vaccinia virus in vitro and in vivo in an intranasal mouse model of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Vaccinia protein kinase 2: a second essential serine/threonine protein kinase encoded by vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus release

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Vaccinia virus K1L protein supports viral replication in human and rabbit cells through a cell-type-specific set of its ankyrin repeat residues that are distinct from its binding site for ACAP2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Vaccinia virus K1L and C7L inhibit antiviral activities induced by type I interferons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

The vaccinia virus F11L gene product facilitates cell detachment and promotes migration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Vaccinia virus host range genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Transient host range selection for genetic engineering of modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Improved host range selection for recombinant modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Genetic engineering of onco/lentivirus hybrids results in formation of infectious but not of replication-competent viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Smallpox vaccination and its consequences: first experiences with the highly attenuated smallpox vaccine "MVA".

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Vaccinia virus-induced cell motility requires F11L-mediated inhibition of RhoA signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

The effect of the vaccinia K1 protein on the PKR-eIF2alpha pathway in RK13 and HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Marker rescue of the host range restriction defects of modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.05.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2010.05.008

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

release_fihj2j3vgjhhrkw4cpzozzjlo4

1 reference

https://api.fatcat.wiki/v0/release/fihj2j3vgjhhrkw4cpzozzjlo4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39680805&oldid=1855526824"